• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antiviral effects of Yinhuapinggan granule against influenza virus infection in the ICR mice model

tetano

Editor, Senior Moderator
J Nat Med. 2015 Oct 6. [Epub ahead of print]
[h=1]Antiviral effects of Yinhuapinggan granule against influenza virus infection in the ICR mice model.[/h] Peng XQ[SUP]1[/SUP], Zhou HF[SUP]1[/SUP], Zhang YY[SUP]1[/SUP], Yang JH[SUP]1[/SUP], Wan HT[SUP]2[/SUP], He Y[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Yinhuapinggan granule (YHPG), a Chinese medicine granule based on Ma-Huang-Tang (Ephedra Decoction) and the clinical experience of Professor Wan Haitong, is used in traditional Chinese medicine (TCM) for the treatment of colds, influenza, fever, inflammation and cough. This study investigated the antiviral effects of YHPG on the production of inflammatory cytokines in influenza virus (IFV)-infected mice and evaluated the effect of YHPG on the expression of NF-κB p65 and the level of key signaling molecules in the TLR4 signaling pathway. ICR mice were orally administrated YHPG at doses of 7.5, 15 and 30 g kg[SUP]-1[/SUP] day[SUP]-1[/SUP] for 2 or 6 days after IFV infection. On days 3 and 7 after infection, YHPG (15 g/kg and 30 g/kg) significantly increased levels of interleukin (IL)-2 and interferon gamma and decreased levels of IL-4, IL-5 and tumor necrosis factor (TNF) in serum compared with the IFV control group. Furthermore, the expression of TLR4, MyD88, TRAF6 and NF-κB p65 at the mRNA and protein level was significantly lower in the YHPG (15 and 30 g/kg) treatment groups than in the IFV control group. These results suggest that YHPG has antiviral effects in IFV-infected mice, which is associated with the inhibition of the TLR4-MyD88-TRAF6 signaling pathway and the expression of NF-κB p65.


[h=4]KEYWORDS:[/h] Antiviral effects; MyD88; NF-κB p65; TLR4; TRAF6; Yinhuapinggan granule

PMID: 26439479 [PubMed - as supplied by publisher]
 
Back
Top Bottom